Clonitazene
Systematic (IUPAC) name | |
---|---|
2-[2-[(4-chlorophenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine | |
Clinical data | |
Identifiers | |
3861-76-5 | |
None | |
PubChem | CID 62528 |
DrugBank | DB01523 |
ChemSpider | 56301 |
UNII | S90R21A2V2 |
ChEMBL | CHEMBL2104616 |
Synonyms | Clonitazene |
Chemical data | |
Formula | C20H23ClN4O2 |
386.88 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
Clonitazene is an opioid analgesic of approximately three times the potency of morphine. It is related to etonitazene, an opioid of significantly higher potency. Clonitazene is not currently marketed. It is a controlled substance; in the United States it is a Schedule I Narcotic controlled substance with a DEA ACSCN of 9612 and an annual manufacturing quota of zero.
Synthesis
References
- ↑ Hunger, A.; Kebrle, J.; Rossi, A.; Hoffmann, K. (1957). "Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate". Experientia 13 (10): 400. doi:10.1007/BF02161116.